The Indian Council of Medical Research has invited vaccine manufacturers, pharma companies, R&D institutions, and in-vitro diagnostic kit manufacturers to develop vaccine and diagnostic kits to tackle the Monkeypox virus outbreak.
The selected organisation will receive a minimum 5% royalty from the products sales for a period of at least 20 years.
The partner organisation will also be allowed to undertake further R&D, manufacture, sell, and commercialise the vaccine and diagnostic kits. For this, ICMR will not only make available the Monkeypox virus strain, but also provide expert guidance and technical support.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.